Gene · 2767
Papers2,923
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 2,923
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Atypical presentation of a late-onset blue nevus. | JAAD Case Rep | 2022 | 36425659 | PubTator, text mining | PubMed |
| GNAQ mutations drive port wine birthmark-associated Sturge-Weber syndrome: A review of pathobiology, therapies, and current models. | Front Hum Neurosci | 2022 | 36405075 | PubTator, text mining | PubMed |
| Towards a single-assay approach: a combined DNA/RNA sequencing panel eliminates diagnostic redundancy and detects clinically-relevant fusions in neuropathology. | Acta Neuropathol Commun | 2022 | 36397144 | PubTator, text mining | PubMed |
| Construction of a 10-gene prognostic score model of predicting recurrence for laryngeal cancer. | Eur J Med Res | 2022 | 36376905 | PubTator, text mining | PubMed |
| Genetic Analyses of Cell-Free DNA in Pancreatic Juice or Bile for Diagnosing Pancreatic Duct and Biliary Tract Strictures. | Diagnostics (Basel) | 2022 | 36359547 | PubTator, text mining | PubMed |
| Differential properties of KRAS transversion and transition mutations in non-small cell lung cancer: associations with environmental factors and clinical outcomes. | BMC Cancer | 2022 | 36348317 | PubTator, text mining | PubMed |
| Pharmacological blockade of TEAD-YAP reveals its therapeutic limitation in cancer cells. | Nat Commun | 2022 | 36347861 | PubTator, text mining | PubMed |
| Autoantibodies - enemies, and/or potential allies? | Front Immunol | 2022 | 36341384 | PubTator, text mining | PubMed |
| Methylation-driven gene DLL3 is a potential prognostic biomarker in ocular melanoma correlating with metastasis. | Front Oncol | 2022 | 36338696 | PubTator, text mining | PubMed |
| Longest survival with primary intracranial malignant melanoma: A case report and literature review. | World J Clin Cases | 2022 | 36338197 | PubTator, text mining | PubMed |
| [Syndrome of hypocalсiuric hypercalcemia. Is it rare? Two clinical cases in an outpatient clinic]. | Probl Endokrinol (Mosk) | 2022 | 36337015 | PubTator, text mining | PubMed |
| Structure insights into selective coupling of G protein subtypes by a class B G protein-coupled receptor. | Nat Commun | 2022 | 36335102 | PubTator, text mining | PubMed |
| Metabolomic, Lipidomic, Transcriptomic, and Metagenomic Analyses in Mice Exposed to PFOS and Fed Soluble and Insoluble Dietary Fibers. | Environ Health Perspect | 2022 | 36331819 | PubTator, text mining | PubMed |
| Identification and validation of a novel signature as a diagnostic and prognostic biomarker in colorectal cancer. | Biol Direct | 2022 | 36319976 | PubTator, text mining | PubMed |
| The cAMP-signaling cancers: Clinically-divergent disorders with a common central pathway. | Front Endocrinol (Lausanne) | 2022 | 36313756 | PubTator, text mining | PubMed |
| Prognostic role of HPV integration status and molecular profile in advanced anal carcinoma: An ancillary study to the epitopes-HPV02 trial. | Front Oncol | 2022 | 36313663 | PubTator, text mining | PubMed |
| Multisite gynecologic endometrioid adenocarcinomas: Can mutation profiling be used to distinguish synchronous primary cancers from metastases? | Gynecol Oncol Rep | 2022 | 36299398 | PubTator, text mining | PubMed |
| Integrating Genetic Alterations and the Hippo Pathway in Head and Neck Squamous Cell Carcinoma for Future Precision Medicine. | J Pers Med | 2022 | 36294681 | PubTator, text mining | PubMed |
| The Genetic Architecture of Vascular Anomalies: Current Data and Future Therapeutic Perspectives Correlated with Molecular Mechanisms. | Int J Mol Sci | 2022 | 36293054 | PubTator, text mining | PubMed |
| Intrinsic Disorder in BAP1 and Its Association with Uveal Melanoma. | Genes (Basel) | 2022 | 36292588 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2767/papers?page=28